[Remote] Senior Director, US Payer Account Management at Cytokinetics

Remote

Cytokinetics Logo
Not SpecifiedCompensation
Senior (5 to 8 years), Expert & Leadership (9+ years)Experience Level
Full TimeJob Type
UnknownVisa
Biopharmaceutical, Cardiovascular, HealthcareIndustries

Requirements

  • Bachelor's degree with 12+ years’ field-based pharmaceutical/biotech Sales and/or Marketing experience and 5+ years of direct managed care experience
  • 3+ years’ experience leading a team of market access Account Directors
  • Strong consultative and networking capabilities, with established relationships

Responsibilities

  • Manage a team of diverse talent of Payer Account Directors (PADs) deployed across multiple National and Regional payers in the US to achieve agreed upon business objectives
  • Provide strategic guidance to the Payer Accounts Team for market readiness so they can identify potential barriers to access to ensure a successful launch of all products
  • Lead team to ensure appropriate coverage / access of therapies across all assigned customers (Commercial payers, Medicare payers, federal accounts (VA/DoD) and State Medicaid)
  • Develop PAD team to be able to identify barriers to access and develop the solutions to address
  • Lead PAD team to anticipate and evaluate reimbursement scenarios for all sites of care
  • Internal / External subject matter expert (SME) on US coverage, coding, payments, and financial dynamics for the Cytokinetics portfolio of products and lead PAD team to be experts
  • Provide mentorship and guidance to the Account Directors in negotiations and contracting with assigned accounts
  • Guide the team to support relationships with senior executives based on an expert understanding of the customer’s organizational structure and strategic priorities
  • Ensure key metrics are in place to measure success and communicate with senior leadership on strategic impact
  • Create clear messages for dissemination to sales on important payer trends, reimbursement changes, and billing requirements that will affect product utilization
  • Represent the Cytokinetics Market Access Team at priority payer organization meetings and state-based managed care organizations
  • Partner with the Cytokinetics Patient Support Services Team to ensure accurate coverage determinations are rendered and resolve customer issues

Skills

Key technologies and capabilities for this role

Payer Account ManagementMarket AccessGPOsPBMsHealth PlansFormulary AccessManaged CareContracting StrategiesRevenue GrowthTeam Management

Cytokinetics

Develops drugs for muscle function disorders

About Cytokinetics

Cytokinetics focuses on developing medicines that improve muscle function for patients with cardiovascular and neuromuscular diseases. Their products are small molecule drugs designed to either enhance or inhibit muscle function, tailored to specific therapeutic needs. The company has a pipeline of drugs, including omecamtiv mecarbil and reldesemtiv, which are in various stages of clinical trials. Unlike many competitors, Cytokinetics emphasizes rigorous scientific research and has conducted over 50 clinical trials to ensure the effectiveness of its treatments. The goal is to bring new therapies to market that address the unmet needs of patients suffering from conditions like heart failure, ALS, and HCM.

South San Francisco, CaliforniaHeadquarters
1998Year Founded
$58.4MTotal Funding
IPOCompany Stage
Biotechnology, HealthcareIndustries
501-1,000Employees

Risks

Increased competition could impact market share and profitability.
Potential delays in clinical trials could hinder drug commercialization.
Dependence on strategic partnerships may expose Cytokinetics to risks if challenges arise.

Differentiation

Cytokinetics focuses on muscle activators and inhibitors for cardiovascular and neuromuscular diseases.
The company has a robust pipeline including omecamtiv mecarbil and aficamten.
Cytokinetics engages in strategic partnerships, like with Sanofi, to expand market reach.

Upsides

Recent investments indicate strong interest in muscle activators and inhibitors.
Strategic partnerships, like with Sanofi, expand market reach and potential revenue.
Significant funding from Royalty Pharma supports commercial launch and R&D advancements.

Land your dream remote job 3x faster with AI